Manfred Quint

Title: Manfred Quint: Innovator in Monoclonal Antibodies

Introduction

Manfred Quint is a notable inventor based in Wiesbaden, Germany. He has made significant contributions to the field of immunology, particularly through his work on monoclonal antibodies. With a total of 2 patents, his innovations are aimed at improving diagnostic processes for various diseases.

Latest Patents

Quint's latest patents focus on monoclonal antibodies for the selective immunological determination of high molecular weight, intact laminin forms in body fluids. The first patent describes a process for preparing these antibodies and their application in diagnosing diseases. These antibodies are designed to bind specifically to intact, native laminin, particularly to the structures of the laminin P1 domain that are folded in a native manner. The second patent also emphasizes monoclonal antibodies directed to the laminin P1 domain for the same purpose, enhancing the accuracy of disease diagnosis.

Career Highlights

Manfred Quint is associated with Hoechst Aktiengesellschaft, a prominent company in the pharmaceutical and chemical sectors. His work has been instrumental in advancing the understanding and application of monoclonal antibodies in medical diagnostics.

Collaborations

Quint has collaborated with notable colleagues such as Martin Gerl and Cornelia Steinert. Their combined expertise has contributed to the successful development of innovative solutions in immunology.

Conclusion

Manfred Quint's contributions to the field of immunology through his patents on monoclonal antibodies highlight his role as a significant inventor. His work continues to impact the diagnostic landscape, paving the way for advancements in disease detection and treatment.